{
    "root": "f6d3709a-e6b8-442f-84ea-be51e7e26a9f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "divalproex sodium",
    "value": "20250521",
    "ingredients": [
        {
            "name": "DIVALPROEX SODIUM",
            "code": "644VL95AO6"
        },
        {
            "name": "ALCOHOL",
            "code": "3K9958V90M",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16134"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30879"
        },
        {
            "name": "METHACRYLIC ACID",
            "code": "1CS02G8656",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25219"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "TRIETHYL CITRATE",
            "code": "8Z96QXD6UM",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_168426"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "divalproex sodium delayed-release capsules anti-epileptic indicated : monotherapy adjunctive therapy complex partial seizures simple complex absence seizures ; adjunctive therapy patients multiple seizure types include absence seizures ( 1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "divalproex sodium delayed-release capsules may swallowed whole contents may sprinkled soft food . drug/food mixture swallowed immediately ( avoid chewing ) ( 2.2 ) safety doses 60 mg/kg/day established ( 2.1 ) , ( 2.2 ) complex partial seizures : start 10 15 mg/kg/day , increasing 1 week intervals 5 10 mg/kg/day achieve optimal response ; response satisfactory , check valproate plasma level ; full prescribing information conversion monotherapy ( 2.1 ) absence seizures : start 15 mg/kg/day , increasing 1 week intervals 5 10 mg/kg/day seizure control limiting side effects ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": null,
    "adverseReactions": "hepatic disease significant hepatic dysfunction ( 4 , 5.1 ) known mitochondrial disorders caused mutations mitochondrial dna polymerase \u03b3 ( polg ) ( 4 , 5.1 ) suspected polg-related disorder children two years age ( 4 , 5.1 ) known hypersensitivity ( 4 , 5.12 ) urea cycle disorders ( 4 , 5.6 ) prophylaxis migraine headaches : pregnant women , women childbearing potential using effective contraception ( 4 , 8.1 )",
    "indications_original": "Divalproex sodium delayed-release capsules are an anti-epileptic drug indicated for: Monotherapy and adjunctive      therapy of complex partial seizures and simple and complex absence      seizures; adjunctive therapy in patients with multiple seizure types that      include absence seizures ( 1 )",
    "contraindications_original": "Divalproex sodium      delayed-release capsules may be swallowed whole or the contents may be      sprinkled on soft food. The drug/food mixture should be swallowed      immediately (avoid chewing) ( 2.2 ) Safety of doses above 60      mg/kg/day is not established ( 2.1 ), ( 2.2 ) Complex Partial Seizures: Start      at 10 to 15 mg/kg/day, increasing at 1 week intervals by 5 to 10 mg/kg/day      to achieve optimal clinical response; if response is not satisfactory,      check valproate plasma level; see full prescribing information for      conversion to monotherapy ( 2.1 ) Absence Seizures: Start at 15      mg/kg/day, increasing at 1 week intervals by 5 to\u00a0 10 mg/kg/day until      seizure control or limiting side effects ( 2.1 )",
    "adverseReactions_original": "Hepatic disease or significant hepatic dysfunction ( 4 , 5.1 ) Known mitochondrial disorders caused by mutations in      mitochondrial DNA polymerase \u03b3 (POLG) ( 4 , 5.1 ) Suspected POLG-related disorder in children under two      years of age ( 4 , 5.1 ) Known hypersensitivity to the drug ( 4 , 5.12 ) Urea cycle disorders ( 4 , 5.6 ) Prophylaxis of migraine headaches: Pregnant women, women      of childbearing potential not using effective contraception ( 4 , 8.1 )",
    "drug": [
        {
            "name": "divalproex sodium"
        }
    ]
}